Concentrix Cuts Q4 2025 Earnings Guidance


Summary
Concentrix (NASDAQ:CNXC) has updated its Q4 2025 earnings guidance, projecting EPS of 2.850-2.960, below the consensus estimate of 3.180. Revenue guidance is set at $2.5 billion-$2.6 billion, aligning with the consensus. The company also revised its FY 2025 EPS guidance to 11.110-11.230. Concentrix shares fell to $54.99, with analysts adjusting price targets and ratings, reflecting mixed sentiments on the stock’s performance.Market Beat+ 2
Impact Analysis
So basically, Concentrix is signaling some turbulence ahead with its Q4 2025 EPS guidance coming in below expectations at 2.850-2.960 versus the consensus of 3.180. This isn’t just a minor miss; it suggests there might be underlying operational challenges or market headwinds that the company is bracing for. The revenue guidance aligns with expectations, which means the issue might be more about cost pressures or margin compression. The market’s reaction was swift, with shares dropping to $54.99, indicating investor concern. Analysts are mixed, adjusting price targets and ratings, but the consensus still leans towards a ‘Buy’ with a target of $69.50. This could be a buying opportunity if you believe in the company’s long-term strategy, but watch for any further downward revisions or negative news that could erode confidence further. The risk/reward here hinges on whether Concentrix can address these challenges effectively.Market Beat+ 2

